Exact
Sciences EXAS issued the following statement today
following the U.S. Preventive Services Task Force (USPSTF) draft
recommendation statement for colorectal cancer screening.
USPSTF included Cologuard in the draft guidelines as an alternative
screening test, along with CT colonography. The draft guidelines
recommend an "A" rating for colorectal cancer screening starting at age
50 and continuing until age 75. Screening for individuals age 75 through
85 is graded a "C." This approach represents a change from the 2008
recommendations, which assigned specific grades for different tests,
including an "I" rating for stool-based DNA.
Cologuard is a non-invasive, FDA-approved colorectal cancer screening
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in